Adrenal gland
Phaeochromocytoma
A catecholamine-secreting tumour of the adrenal medulla: hypertension (sustained or episodic), palpitations, headache and sweating.
Causes et facteurs de risque
- Mostly sporadic
- Up to 25% familial: MEN 2A and 2B (RET), neurofibromatosis 1 (NF1), von Hippel-Lindau disease (VHL)
Aspect macroscopique
- A grey-tan tumour of the medulla with the yellow adrenal cortex stretched around it.
- Turns brown in dichromate (the chromaffin reaction), from its stored catecholamines.
Au microscope
- Chromaffin cells full of catecholamines.
Évolution
- Chromaffin cells of the medulla form a tumour.
- It secretes noradrenaline and adrenaline, acting on α and β receptors.
- Handling the tumour at surgery can release a surge of catecholamines.
Complications
- Hypertension, tachycardia, palpitations, headache, tremor and sweating
- Cardiac arrhythmias and sudden death
- The “10% rule”: about 10% are bilateral, malignant, in children, non-hypertensive or outside the adrenal
Examens complémentaires
- Plasma or urine metanephrines
- Raised: the breakdown products of the catecholamines the tumour releases.
- CT or MRI of the adrenals
- The adrenal tumour.
- Functional imaging
- MIBG scintigraphy or PET finds tumours outside the adrenal and metastases.
- Genetic testing
- Hereditary syndromes such as MEN 2, von Hippel–Lindau disease and neurofibromatosis type 1.
Traitement médicamenteux
- α-Adrenergic blockers: Drugs that block α1 receptors: selective α1-blockers relax prostate and bladder-neck smooth muscle in benign prostatic hyperplasia; the irreversible blocker phenoxybenzamine protects against the catecholamine surges of phaeochromocytoma.
Médicaments à éviter ou à utiliser avec précaution
- β-Adrenergic blockers (β-blockers) (Contre-indiqué): Blocking β2-mediated vasodilatation leaves the tumour’s catecholamines acting unopposed on α receptors: a dangerous rise in blood pressure. An α-blocker always comes first.
Anatomie concernée
Sujets liés
Rédigé d’après
- Robbins and Cotran Atlas of Pathology, 3rd ed., Ch. 15, The Endocrine System, pp. 405, figs 15-50 to 15-52
Ressource pédagogique. Ne constitue pas un avis, un diagnostic ou un traitement médical.